0RAMVistin Pharma ASA

19.15NOK+0.79%Mkt Cap: —P/E: 34.207d ago

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; m…

Key Statistics

Company

Market Cap—

Enterprise Value78.22M $

Revenue (TTM)42.02M $

Gross Profit27.98M $

Net Income (TTM)6.97M $

Revenue/Share0.9470 USD

Last Price19.15 NOK

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees74

CountryGB

SectorHealthcare

Industry—

ISIN—

Valuation

P/E (Trailing)34.20

P/E (Forward)—

PEG—

EV/EBITDA7.53

EV/Revenue1.86

P/S—

P/B2.41

EPS (TTM)0.56

EPS (Forward)—

52W Range

19.00100% of range19.15

52W High19.15 NOK

52W Low19.00 NOK

Profitability

Gross Margin66.59%

Oper. Margin19.18%

EBITDA Margin24.71%

Profit Margin16.58%

ROE21.88%

ROA12.79%

Growth

Revenue Growth-2.50%

Earnings Growth-1.20%

Cash Flow & Leverage

Operating CF6.44M $

CapEx (TTM)—

FCF Margin3.68%

FCF Yield—

Net Debt-544.70K $

Net Debt/EBITDA-0.05

Balance Sheet

Debt/Equity0.14

Current Ratio2.96

Quick Ratio1.83

Book Value/Sh7.900 NOK

Cash/Share0.1430 NOK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 NOK

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float20.21M

Insiders58.94%

Institutions13.74%

Technical

SMA 5023.21 (-17.5%)

SMA 20023.21 (-17.5%)

Beta0.61

S&P 52W Chg21.00%

Avg Vol (30d)1.07K

Avg Vol (10d)1.00K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

0RAMVistin Pharma ASA

Industry Peers

Key Statistics